Daniel Laverick, Zuellig Pharma
Daniel Laverick, Zuellig Pharma
4 January 2023
Why It Matters: Using technology to build resilience against threats in healthcare
Consumers are increasingly at risk of falling prey to counterfeits and unsafe practices as technology gets more advanced and prevalent. In 2021 alone, malicious agents targeted pharmaceuticals across all therapeutic categories, with 5,987 pharmaceutical crimes affecting 3,160 medications.
Daniel Laverick, Chief Digital & Data Officer, Zuellig Pharma shares how technology can be used to counter this threat and why it matters to the healthcare industry.
Download this podcast.